$ITW

UBS Adjusts Price Target on Illinois Tool Works to $300 From $278, Maintains Neutral Rating

UBS raised its price target on Illinois Tool Works to $300 from $278 and kept a Neutral rating, according to the brokerage. The article provides ITW’s business segment mix and geographic sales distribution but does not cite additional financial results.

Original reporting
Published Jul 29, 2026, 2:47 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 4:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$ITW
Neutral
medium confidence
Mentioned
$ITW
Relevance
6/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$ITWNeutralLow
01

Why it matters

For traders, the key signal is the valuation recalibration (PT up) without a change in stance (Neutral unchanged).

02

Market read

This is a modest sentiment/valuation update rather than a fundamental catalyst.

03

What to watch

The body contains no new ITW-specific operating or guidance information, so traders should rely on the underlying UBS thesis details not included here.

Relevance 6/10Novelty 4/10Timing: as of the UBS note publication date (2026-07-29)

Background

The article is framed as an analyst action: UBS raises ITW's price target but keeps the rating Neutral.

Company-level read

Ticker impact

$ITWNeutralMedium confidence
Context

UBS adjusted Illinois Tool Works' price target to $300 from $278 while keeping a Neutral rating, signaling a valuation view change.

Expected impact

Likely modest, short-lived sentiment impact; Neutral rating reduces probability of sustained re-rating momentum.

Evidence & confidence

The only actionable company-specific detail provided is the UBS PT change and rating hold; no new earnings, guidance, or fundamental datapoint is included.

Market effects

Limited read-through to industrials since the article provides only a single-bank PT adjustment with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

A higher PT with a Neutral rating can reflect incremental valuation support rather than improved fundamentals, so downside risk may remain if operating trends disappoint.

Key entities

  • Illinois Tool Works Inc.

    UBS adjusted its price target to $300 from $278 and maintained a Neutral rating.

Related articles

$ITWMed

Illinois Tool Works’s Q2 Earnings Call: Our Top 5 Analyst Questions

Illinois Tool Works (ITW) reported Q2 revenue of $4.30B vs $4.19B estimates and GAAP EPS of $2.84 vs $2.80, with full-year GAAP EPS guidance of $11.45 at the midpoint. Management cited CapEx-related segment momentum and customer-back innovation for organic revenue growth. Analysts asked about order sustainability, segment growth, innovation measurement, and margin timing.

$NUEMed

ITW and Nucor See Tailwinds Sustaining Manufacturing Growth

Illinois Tool Works (ITW) and Nucor (NUE) executives said on July 28 they expect industrial demand tailwinds from energy, infrastructure, data centers and advanced manufacturing to persist. ITW forecast 2026 organic sales growth of 3% to 4% and 2026 sales of at least $1.8B. Nucor cited multi-year investment cycles. Shares rose: NUE +7% to ~$265, ITW +4% to ~$295.

$ITWMedAI 8/10

Illinois Tool Works Inc. Q2 2026 Earnings Call Summary

Illinois Tool Works (ITW) reported Q2 2026 results with sequential revenue up 7% and operating margin at 26.7%. CapEx-linked segments Welding (+14%) and Test & Measurement and Electronics (+10%) drove growth, while Customer-Back Innovation added 3% to first-half revenue growth. Full-year organic growth guidance midpoint raised to 3.5% and share repurchases of $750M were pulled forward.